DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tussionex (Hydrocodone Polistirex / Chlorpheniramine Polistirex) - Indications and Dosage

 



INDICATIONS AND USAGE

TUSSIONEX Pennkinetic Extended-Release Suspension is indicated for relief of cough and upper respiratory symptoms associated with allergy or a cold.

DOSAGE AND ADMINISTRATION

Shake well before using.

Adults: 1 teaspoonful (5 mL) every 12 hours; do not exceed 2 teaspoonfuls in 24 hours.

Children 6-12: 1/2 teaspoonful every 12 hours; do not exceed 1 teaspoonful in 24 hours.

Not recommended for children under 6 years of age (see PRECAUTIONS).

HOW SUPPLIED

TUSSIONEX Pennkinetic (hydrocodone polistirex and chlorpheniramine polistirex) Extended-Release Suspension is a gold-colored suspension.

NDC 53014-548-67      473 mL bottle

Shake well. Dispense in a well-closed container. Store at 59°-86°F (15°-30°C).

Celltech Pharmaceuticals, Inc.

Rochester, NY 14623 USA

© 2002, Celltech Pharmaceuticals, Inc.

® Celltech Manufacturing, Inc.

Tussionex® Pennkinetic® Extended-Release Suspension: US Patent No. 4,762,709.2

Rev. 12/02

LR242A

Page last updated: 2006-04-08

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009